Melola Discovery

← Melola Discovery

Akses terbuka Jurnal SINTA 1

Stability and Efficacy of Live-Attenuated Vibrio harveyi Vaccines Under Different Storage Conditions in Zebrafish (Danio rerio) Models

Jurnal Ilmiah Perikanan dan Kelautan · Vol. 16 No. 2 (2024) · hlm. 322–335

DOI
10.20473/jipk.v16i2.59794
ISSN
2528-0759, 2085-5842
Terbit
2024-09-21
Penerbit
Faculty of Fisheries and Marine Universitas Airlangga
Bahasa
eng
Lisensi
creativecommons.org/licenses/by-nc-sa/4.0

Abstrak

Graphical Abstract Highlight Research The LD50 (median lethal dose) of Vibrio parahaemolyticus and harveyi in zebrafish was determined to be 1 x 106 CFU/mL, while for V. alginolyticus it was found to be 1 x 105 CFU/mL. The LAVh vaccine demonstrated cross-protection against various pathogenic strains of Vibrio, leading to an average of 80% survival rate in vaccinated individuals. The analysis of the LAVh vaccine emphasized its versatility, as it can be quickly deployed and stored as a freeze-dried powder. The LAVh vaccine can be easily accessible and user-friendly in various aquaculture environments, such as offshore and remote farms. Abstract Vibriosis poses a significant threat to marine teleosts, causing substantial losses in the global aquaculture industry. Previous work in our lab led to the development of a live-attenuated V. harveyi vaccine (LAVh) candidate that targets the serine endoprotease gene with a three-point knockout and has shown promise in protecting against vibriosis. However, further investigation is necessary to evaluate the stability and efficacy of its various storage conditions for broader applications. This study aims to determine how well the three different LAVh vaccine storage (fresh, stale, and freeze-dried LAVh) worked against vibriosis. A total of 1000 adult zebrafish (Danio rerio) (mean weight: 0.20±0.5 g) were divided into four groups. Groups 1, 2, and 3 were intraperitoneally injected with different LAVh vaccine storage (fresh, stale, and freeze-dried, respectively), while Group 4 received 0.01 M phosphate-buffered saline (PBS) and served as the unvaccinated control. Fish were monitored for 21 days post-vaccination for safety, stability, efficacy, and antibody analysis. The results showed that a modest dosage of 1 x 104 CFU/mL of LAVh vaccine from all storage conditions provided 80% survival upon intraperitoneal challenge with pathogenic strains of pathogenic V. harveyi, V. alginolyticus, and V. parahaemolyticus. This dosage induced significant antibody production and conferred cross-protection against different Vibrio spp., indicating the LAVh vaccine’s potential for commercial application. The LAVh vaccine demonstrated high effectiveness and suitability for storage as a freeze-dried powder. This study might offer significant insights into practical strategies for reducing vibriosis, especially in aquaculture settings with limited infrastructure.

Kata kunci

Jaringan kolaborasi para penulis

40 penulis · 189 tautan kepenulisan bersama · 54 lintas organisasi · menampilkan 40 yang paling banyak terhubung

Arahkan kursor atau ketuk sebuah nama untuk menyorot rekan penulisnya. Klik dua kali untuk membuka halaman penulis.

  • Universiti Putra Malaysia
  • Universitas Airlangga
  • Bangladesh Fisheries Research Institute
  • IPB University
  • National University of Sciences and Technology
  • Diponegoro University
  • Afiliasi tidak diketahui
  • Organisasi berbeda
  • Organisasi sama
  • Afiliasi tidak diketahui
  • Garis lebih tebal = lebih banyak artikel bersama · lingkaran lebih besar = lebih banyak artikel
Tampilkan sebagai tabel
Rekan penulisOrganisasiArtikel bersama
Annas SallehUniversiti Putra Malaysia4
Hasliza Abu HassimUniversiti Putra Malaysia3
Woro Hastuti SatyantiniUniversitas Airlangga3
A. A. AffanUniversiti Putra Malaysia2
Anuraga JayanegaraIPB University2
Aslah MohamadUniversiti Putra Malaysia2
Syafiq-Aizat HamidUniversiti Putra Malaysia2
Khozirah ShaariUniversiti Putra Malaysia2
Muhammad Farhan NazarudinUniversiti Putra Malaysia2
SuwarnoDiponegoro University1
Suryo KuncorojatiAfiliasi tidak diketahui1
Mohammad Anam Al ArifUniversitas Airlangga1
Rahayu KusdarwatiUniversitas Airlangga1
Putri Desi Wulan SariUniversitas Airlangga1
Jola RahmahaniUniversitas Airlangga1
RoziUniversitas Airlangga1
Wiwiek TyasningsihUniversitas Airlangga1
Eduardus Bimo AksonoUniversitas Airlangga1
Muchammad YunusUniversitas Airlangga1
Nadeem KhanandNational University of Sciences and Technology1
FMA AmirulAfiliasi tidak diketahui1
S AnnasUniversiti Putra Malaysia1
AAA GhaniUniversiti Putra Malaysia1
HA HassimUniversiti Putra Malaysia1
A.B. ZukiUniversiti Putra Malaysia1
Aida Firdaus Muhammad Nurul AzmiUniversiti Putra Malaysia1
A.A.A. GhaniUniversiti Putra Malaysia1
A.S. SaadanUniversiti Putra Malaysia1
Mokrish AjatAfiliasi tidak diketahui1
Kok‐Song LaiUniversiti Putra Malaysia1
Nur Diyana Mohamad TahirUniversiti Putra Malaysia1
Yap Sing YeeUniversiti Putra Malaysia1
PatmawatiAfiliasi tidak diketahui1

Afiliasi berasal dari OpenAlex; metadata OAI-PMH jurnal tidak memuatnya. Penulis tanpa ID OpenAlex dicocokkan berdasarkan nama, sehingga dua orang bisa tergabung atau satu orang bisa terpisah.

Sumber metadata: OAI-PMH (metadata jurnal) https://e-journal.unair.ac.id/index.php/JIPK/oai, pertama di-harvest 9 Nov 2026, terakhir terlihat 9 Nov 2026.
Metadata asli (oai_dc)
<oai_dc:dc xmlns="http://www.openarchives.org/OAI/2.0/" xmlns:dc="http://purl.org/dc/elements/1.1/" xmlns:oai_dc="http://www.openarchives.org/OAI/2.0/oai_dc/" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xsi:schemaLocation="http://www.openarchives.org/OAI/2.0/oai_dc/  http://www.openarchives.org/OAI/2.0/oai_dc.xsd">
	<dc:title xml:lang="en-US">Stability and Efficacy of Live-Attenuated Vibrio harveyi Vaccines Under Different Storage Conditions in Zebrafish (Danio rerio) Models</dc:title>
	<dc:creator>Muhamad-Sofie, Mohd Hafiz Ngoo </dc:creator>
	<dc:creator>Mohamad, Aslah</dc:creator>
	<dc:creator>Azzam-Sayuti, Mohamad</dc:creator>
	<dc:creator>Amal, Mohammad Noor Azmai </dc:creator>
	<dc:creator>Zamri-Saad, Mohd</dc:creator>
	<dc:creator>Monir, Md Shirajum</dc:creator>
	<dc:creator>Md Yasin, Ina Salwany</dc:creator>
	<dc:subject xml:lang="en-US">Live-attenuated vaccine</dc:subject>
	<dc:subject xml:lang="en-US">Vibriosis</dc:subject>
	<dc:subject xml:lang="en-US">Vibrio spp.</dc:subject>
	<dc:subject xml:lang="en-US">Freeze-dried vaccine</dc:subject>
	<dc:description xml:lang="en-US">Graphical Abstract

Highlight Research

The LD50 (median lethal dose) of Vibrio parahaemolyticus and  harveyi in zebrafish was determined to be 1 x 106 CFU/mL, while for V. alginolyticus it was found to be 1 x 105 CFU/mL.
The LAVh vaccine demonstrated cross-protection against various pathogenic strains of Vibrio, leading to an average of 80% survival rate in vaccinated individuals.
The analysis of the LAVh vaccine emphasized its versatility, as it can be quickly deployed and stored as a freeze-dried powder.
The LAVh vaccine can be easily accessible and user-friendly in various aquaculture environments, such as offshore and remote farms.

Abstract
Vibriosis poses a significant threat to marine teleosts, causing substantial losses in the global aquaculture industry. Previous work in our lab led to the development of a live-attenuated V. harveyi vaccine (LAVh) candidate that targets the serine endoprotease gene with a three-point knockout and has shown promise in protecting against vibriosis. However, further investigation is necessary to evaluate the stability and efficacy of its various storage conditions for broader applications. This study aims to determine how well the three different LAVh vaccine storage (fresh, stale, and freeze-dried LAVh) worked against vibriosis. A total of 1000 adult zebrafish (Danio rerio) (mean weight: 0.20±0.5 g) were divided into four groups. Groups 1, 2, and 3 were intraperitoneally injected with different LAVh vaccine storage (fresh, stale, and freeze-dried, respectively), while Group 4 received 0.01 M phosphate-buffered saline (PBS) and served as the unvaccinated control. Fish were monitored for 21 days post-vaccination for safety, stability, efficacy, and antibody analysis. The results showed that a modest dosage of 1 x 104 CFU/mL of LAVh vaccine from all storage conditions provided 80% survival upon intraperitoneal challenge with pathogenic strains of pathogenic V. harveyi, V. alginolyticus, and V. parahaemolyticus. This dosage induced significant antibody production and conferred cross-protection against different Vibrio spp., indicating the LAVh vaccine’s potential for commercial application. The LAVh vaccine demonstrated high effectiveness and suitability for storage as a freeze-dried powder. This study might offer significant insights into practical strategies for reducing vibriosis, especially in aquaculture settings with limited infrastructure.</dc:description>
	<dc:publisher xml:lang="en-US">Faculty of Fisheries and Marine Universitas Airlangga</dc:publisher>
	<dc:date>2024-09-21</dc:date>
	<dc:type>info:eu-repo/semantics/article</dc:type>
	<dc:type>info:eu-repo/semantics/publishedVersion</dc:type>
	<dc:format>text/xml</dc:format>
	<dc:format>application/pdf</dc:format>
	<dc:identifier>https://e-journal.unair.ac.id/JIPK/article/view/59794</dc:identifier>
	<dc:identifier>10.20473/jipk.v16i2.59794</dc:identifier>
	<dc:source xml:lang="en-US">Jurnal Ilmiah Perikanan dan Kelautan; Vol. 16 No. 2 (2024): JURNAL ILMIAH PERIKANAN DAN KELAUTAN; 322-335</dc:source>
	<dc:source>2528-0759</dc:source>
	<dc:source>2085-5842</dc:source>
	<dc:language>eng</dc:language>
	<dc:relation>https://e-journal.unair.ac.id/JIPK/article/view/59794/41500</dc:relation>
	<dc:relation>https://e-journal.unair.ac.id/JIPK/article/view/59794/30153</dc:relation>
	<dc:rights xml:lang="en-US">Copyright (c) 2024 Jurnal Ilmiah Perikanan dan Kelautan</dc:rights>
	<dc:rights xml:lang="en-US">http://creativecommons.org/licenses/by-nc-sa/4.0</dc:rights>
</oai_dc:dc>